• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4612197)   Today's Articles (4505)   Subscriber (49382)
For: Stauber RE, Hofer H, Hackl F, Schütze K, Datz C, Hegenbarth K, Jessner W, Steindl-Munda P, Peter F. Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine. Wien Klin Wochenschr 2004;116:530-5. [PMID: 15471180 DOI: 10.1007/bf03217706] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Number Cited by Other Article(s)
1
Pol S, Bourlière M. Optimizing Treatment Outcomes in Chronic Hepatitis C: Management of Non-Response. Antivir Ther 2006. [DOI: 10.1177/135965350601100815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
2
Hofer H, Gurguta C, Bergholz U, Steindl-Munda P, Ferenci P. Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia. Wien Klin Wochenschr 2006;118:595-600. [PMID: 17136334 DOI: 10.1007/s00508-006-0704-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2006] [Accepted: 06/28/2006] [Indexed: 12/12/2022]
3
Fargion S, Borzio M, Maraschi A, Cargnel A. Triple antiviral therapy in HCV positive patients who failed prior combination therapy. World J Gastroenterol 2006;12:5293-300. [PMID: 16981257 PMCID: PMC4088194 DOI: 10.3748/wjg.v12.i33.5293] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]  Open
4
Ferenci P, Formann E, Laferl H, Gschwantler M, Hackl F, Brunner H, Hubmann R, Datz C, Stauber R, Steindl-Munda P, Kessler HH, Klingler A, Gangl A. Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection. J Hepatol 2006;44:275-82. [PMID: 16338019 DOI: 10.1016/j.jhep.2005.09.015] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2005] [Revised: 09/07/2005] [Accepted: 09/20/2005] [Indexed: 12/04/2022]
5
Vogel W. Treatment of chronic hepatitis C patients not responding to combination therapy with ribavirin and interferon α — hype or hope? Wien Klin Wochenschr 2004;116:508-10. [PMID: 15471176 PMCID: PMC7088274 DOI: 10.1007/bf03217702] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA